ExploreWatchlistsPricing
  1. JP-listed companies
  2. SUZUKEN CO.,LTD.
  3. Financials
  4. Net income

SUZUKEN CO.,LTD. (9987)

Market cap
¥432.6B
P/E ratio
13.2x
Suzuken distributes prescription drugs, medical devices and diagnostic products to healthcare providers across Japan through a nationwide network of subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202534,503+18.91%
Mar 31, 202429,016+42.62%
Mar 31, 202320,345+40.58%
Mar 31, 202214,472+80.95%
Mar 31, 20217,998-71.72%
Mar 31, 202028,279-6.90%
Mar 31, 201930,376+60.36%
Mar 31, 201818,942-11.43%
Mar 31, 201721,387-26.30%
Mar 31, 201629,020+52.99%
Mar 31, 201518,969+26.70%
Mar 31, 201414,971+54.10%
Mar 31, 20139,715+525.16%
Mar 31, 20121,554

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat